Molbio Diagnostics, a molecular diagnostics company, has announced a $30 million investment in OptraSCAN, a San Jose-based diagnostics company. The partnership seeks to enhance accessibility to advanced digital pathology solutions powered by artificial intelligence. The initiative focuses on cloud-based systems for slide scanning, image analysis, and secure data storage, aiming to enable faster and more accurate diagnoses for healthcare providers worldwide.
Sriram Natarajan, CEO of Molbio Diagnostics, said, “At Molbio Diagnostics, we believe that access to timely and accurate diagnostics should not be a privilege but a right. This strategic alliance with OptraSCAN represents a significant step in our mission to make high-quality, affordable healthcare accessible to all by bringing innovative digital pathology solutions in India and beyond, empowering clinicians with the technology needed to enhance patient care.”
OptraSCAN’s solutions are tailored for diverse healthcare environments, including small laboratories and large medical facilities. Through this partnership, OptraSCAN plans to expand its product range and increase the availability of diagnostic technology in rural and under-resourced areas in India.
Abhi Gholap, Founder and CEO of OptraSCAN, said, “OptraSCAN is thrilled to have Molbio Diagnostics as a strategic partner who shares our dedication to innovation and expanding access to quality healthcare. This partnership will allow us to bring life-saving digital pathology solutions to a wider market, helping laboratories of all sizes make timely, precise diagnoses possible. Together with Molbio, we aim to bridge gaps in healthcare by delivering technology that supports high-quality, affordable diagnostics globally.”
The collaboration will also advance the development of AI-driven pathology solutions, empowering healthcare professionals to diagnose diseases more efficiently. The investment will strengthen OptraSCAN’s research and development efforts, enhance its global footprint, and bring advanced diagnostic tools to regions with limited healthcare infrastructure.